Articles

Elsevier,

Current Developments in Nutrition, Volume 6, 1 April 2022

This study compares GM (Growth Monitoring) manuals from Tanzania, India and The Netherlands with each other, and with the materials for the WHO’s training course on child growth assessment.
Graphical abstract
Elsevier
Nanomaterials including engineered nanomaterials and nanoplastics emerge as new pollutants to the ecosystem. In particular, studies on the adverse effects of nanomaterials on the brain are limited. Various animal models offer opportunities to evaluate neurological effects of nanomaterials. We summarize recent studies and key findings on neurotoxicological effects of nanomaterials, focusing on zebrafish.
Elsevier,

Journal of Integrative Agriculture, Volume 21, April 2022

Using agronomic experiment data from 62 studies between 1987 and 2021, we employ a meta-analysis to analyze the factors contributing to the heterogeneous effects of wastewater irrigation on crop yield.
Elsevier,

Advances in Radiation Oncology, 2022, 100955

Helping Ukraine during the crisis.
 A schematic diagram of the protein structure of Fibrocystin (FPC) and DZIP1L
Elsevier,

Biochimica et Biophysica Acta - Molecular Basis of Disease, Volume 1868, 1 April 2022

ARPKD is a rare disease. This review explores the genetics of ARPKD and is accompanied by a short video by the author with a summary of the article.
Elsevier,

Advances in Radiation Oncology,
2022,
100957,

For Ukrainian pediatric cancer patients receiving care outside of their nation's borders on February 24, 2022, the Russian invasion of Ukraine compounded these problems.
Elsevier,

The Lancet Regional Health - Europe, Volume 15, April 2022

An article on dementia risk, in the context of SDGs 3 and 10, focusing specifically on the association between ethnicity, socioeconomic deprivation, and dementia risk.
Cross-sectional and longitudinal soluble TREM2 levels in CSF according to estimated years to symptom onset (EYO) in carriers and non-carriers of pathogenic variants.
Elsevier,

The Lancet Neurology, Volume 21, April 2022

An article on Alzheimer's disease progression, in the context of SDG 3, focusing specifically on the dynamics of soluble TREM2 and its association with amyloid and tau markers, neuroimaging features, and cognition.
Elsevier,

The Lancet Healthy Longevity, Volume 3, April 2022

An article on interventions for people with mild dementia, in the context of SDG 3, focusing specifically on the benefits and cost-effectiveness of the Journeying through Dementia intervention in England.
Elsevier,

Frontiers in Neuroendocrinology, Volume 65, April 2022

In vitro and in vivo studies showed that melatonin therapy is effective against AD. The emerging novel melatonin-based therapies are potential treatment options in AD.

Pages